Kenvue

Kenvue Inc.
Company typePublic
IndustryConsumer products
PredecessorJohnson & Johnson (consumer health division)
FoundedFebruary 23, 2022; 2 years ago (2022-02-23) in Wilmington, Delaware, U.S.[1]
Headquarters
Skillman, New Jersey
,
U.S.
Area served
Worldwide
Key people
Products
RevenueIncrease US$15.44 billion (2023)
Decrease US$2.512 billion (2023)
Decrease US$1.664 billion (2023)
Total assetsIncrease US$27.85 billion (2023)
Total equityDecrease US$11.21 billion (2023)
Number of employees
c. 22,000 (2023)
SubsidiariesMcNeil Consumer Healthcare
Websitekenvue.com
Footnotes / references
[2]

Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson,[3] Kenvue is the proprietor of well-known brands such as Aveeno,[4] Band-Aid,[5] Benadryl, Combantrin, Zyrtec,[6] Johnson's,[7] Listerine,[8] Mylanta, Neutrogena,[4] Trosyd, Calpol, Tylenol,[8] and Visine.

Kenvue is incorporated under the Delaware General Corporation Law[1] and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey.[9] Before the spin-off, Johnson & Johnson's consumer health division was based in Skillman, even as its pharmaceutical division and medical technologies division, as well as the overall company headquarters, were located in nearby New Brunswick, New Jersey.

  1. ^ a b Cite error: The named reference sec 2023-04-24 was invoked but never defined (see the help page).
  2. ^ "Kenvue Inc. 2023 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. March 1, 2024.
  3. ^ Chapman, Michelle; Murphy, Tom (November 12, 2021). "Johnson & Johnson to split into two, aim for faster growth". Associated Press. Retrieved May 7, 2023.
  4. ^ a b Kenvue Inc. (July 24, 2023). "Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement". Business Wire (English).
  5. ^ "Kenvue Showcases Tylenol Precise Cream, First Launch Since IPO". MMR. 40 (10): 18. September 11, 2023.
  6. ^ Altman, Michael; Atasu, Atalay; Özkaya, Evren (October 18, 2023). "How Kenvue De-Risked Its Supply Chain". Harvard Business Review Digital Articles: 1–8.
  7. ^ Kenvue Inc. (April 5, 2023). "Kenvue to Begin Trading on the New York Stock Exchange". Business Wire (English).
  8. ^ a b Lipschultz, Bailey (June 6, 2023). "Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Year's Biggest IPO". Bloomberg.com: N.PAG.
  9. ^ "J&J Spinoff Kenvue Locating HQ in Summit", New Jersey Business Magazine, May 1, 2023. Accessed August 29, 2023. "Kenvue, the multibillion-dollar spinoff of Johnson & Johnson’s consumer health business, has chosen to locate its global headquarters in Summit.... Kenvue's product portfolio includes well known products Tylenol, Neutrogena, Listerine and Band-Aid, and the spinoff marks the largest restructuring in Johnson & Johnson's 135-year history.... Currently located in Skillman, Kenvue will slowly make a transition to the Summit East campus."